Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Dominant Role for Regulatory T Cells in Protecting Females Against Pulmonary Hypertension.

Tamosiuniene R, Manouvakhova O, Mesange P, Saito T, Qian J, Sanyal M, Lin YC, Nguyen LP, Luria A, Tu AB, Sante JM, Rabinovitch M, Fitzgerald DJ, Graham BB, Habtezion A, Voelkel NF, Aurelian L, Nicolls MR.

Circ Res. 2018 Jun 8;122(12):1689-1702. doi: 10.1161/CIRCRESAHA.117.312058. Epub 2018 Mar 15.

2.

Absence of T cells confers increased pulmonary arterial hypertension and vascular remodeling.

Taraseviciene-Stewart L, Nicolls MR, Kraskauskas D, Scerbavicius R, Burns N, Cool C, Wood K, Parr JE, Boackle SA, Voelkel NF.

Am J Respir Crit Care Med. 2007 Jun 15;175(12):1280-9. Epub 2007 Apr 5.

3.

Significance of endothelial prostacyclin and nitric oxide in peripheral and pulmonary circulation.

Gryglewski RJ, Chłopicki S, Uracz W, Marcinkiewicz E.

Med Sci Monit. 2001 Jan-Feb;7(1):1-16.

PMID:
11208485
4.

Simvastatin protects against the development of monocrotaline-induced pulmonary hypertension in rats via a heme oxygenase-1-dependent pathway.

Zhang WH, Zhang YJ, Liu CP, Yu BX, Lu WX.

Exp Lung Res. 2011 Oct;37(8):492-9. doi: 10.3109/01902148.2011.591892. Epub 2011 Aug 25.

PMID:
21867382
5.

Severe pulmonary arterial hypertension induced by SU5416 and ovalbumin immunization.

Mizuno S, Farkas L, Al Husseini A, Farkas D, Gomez-Arroyo J, Kraskauskas D, Nicolls MR, Cool CD, Bogaard HJ, Voelkel NF.

Am J Respir Cell Mol Biol. 2012 Nov;47(5):679-87. doi: 10.1165/rcmb.2012-0077OC. Epub 2012 Jul 27.

6.

C-type natriuretic peptide does not attenuate the development of pulmonary hypertension caused by hypoxia and VEGF receptor blockade.

Casserly B, Mazer JM, Vang A, Harrington EO, Klinger JR, Rounds S, Choudhary G.

Life Sci. 2011 Sep 26;89(13-14):460-6. doi: 10.1016/j.lfs.2011.07.009. Epub 2011 Jul 27.

7.

Endothelial Krüppel-like factor 4 modulates pulmonary arterial hypertension.

Shatat MA, Tian H, Zhang R, Tandon G, Hale A, Fritz JS, Zhou G, Martínez-González J, Rodríguez C, Champion HC, Jain MK, Hamik A.

Am J Respir Cell Mol Biol. 2014 Mar;50(3):647-53. doi: 10.1165/rcmb.2013-0135OC.

8.

Augmented renal prostacyclin by intrarenal bicistronic cyclo-oxygenase-1/prostacyclin synthase gene transfer attenuates renal ischemia-reperfusion injury.

Yang CC, Chen KH, Hsu SP, Chien CT.

Transplantation. 2013 Dec 27;96(12):1043-51. doi: 10.1097/TP.0b013e3182a77e52.

PMID:
24092384
9.

Inhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell death-dependent pulmonary endothelial cell proliferation and severe pulmonary hypertension.

Taraseviciene-Stewart L, Kasahara Y, Alger L, Hirth P, Mc Mahon G, Waltenberger J, Voelkel NF, Tuder RM.

FASEB J. 2001 Feb;15(2):427-38.

PMID:
11156958
10.

Endothelial-like progenitor cells engineered to produce prostacyclin rescue monocrotaline-induced pulmonary arterial hypertension and provide right ventricle benefits.

Zhou L, Chen Z, Vanderslice P, So SP, Ruan KH, Willerson JT, Dixon RA.

Circulation. 2013 Aug 27;128(9):982-94. doi: 10.1161/CIRCULATIONAHA.113.003139. Epub 2013 Jul 10.

PMID:
23841984
11.

Effects of IL-1beta, TNF-alpha, and macrophage migration inhibitory factor on prostacyclin synthesis in rat pulmonary artery smooth muscle cells.

Itoh A, Nishihira J, Makita H, Miyamoto K, Yamaguchi E, Nishimura M.

Respirology. 2003 Dec;8(4):467-72.

PMID:
14629650
12.

Heme oxygenase-1 reduces murine monocrotaline-induced pulmonary inflammatory responses and resultant right ventricular overload.

Goto J, Ishikawa K, Kawamura K, Watanabe Y, Matumoto H, Sugawara D, Maruyama Y.

Antioxid Redox Signal. 2002 Aug;4(4):563-8.

PMID:
12230867
13.

Regulatory T cells limit vascular endothelial injury and prevent pulmonary hypertension.

Tamosiuniene R, Tian W, Dhillon G, Wang L, Sung YK, Gera L, Patterson AJ, Agrawal R, Rabinovitch M, Ambler K, Long CS, Voelkel NF, Nicolls MR.

Circ Res. 2011 Sep 30;109(8):867-79. doi: 10.1161/CIRCRESAHA.110.236927. Epub 2011 Aug 25.

14.

Increased pulmonary heme oxygenase-1 and delta-aminolevulinate synthase expression in monocrotaline-induced pulmonary hypertension.

Iwasaki T, Takahashi T, Shimizu H, Ohmori E, Morimoto T, Kajiya M, Takeuchi M, Morita K, Akagi R, Kajiya F.

Curr Neurovasc Res. 2005 Apr;2(2):133-9.

PMID:
16181105
15.

Simvastatin ameliorates established pulmonary hypertension through a heme oxygenase-1 dependent pathway in rats.

Hsu HH, Ko WJ, Hsu JY, Chen JS, Lee YC, Lai IR, Chen CF.

Respir Res. 2009 May 2;10:32. doi: 10.1186/1465-9921-10-32.

16.

Prevention of hypoxia-induced pulmonary hypertension by enhancement of endogenous heme oxygenase-1 in the rat.

Christou H, Morita T, Hsieh CM, Koike H, Arkonac B, Perrella MA, Kourembanas S.

Circ Res. 2000 Jun 23;86(12):1224-9. Erratum in: Circ Res 2002 Mar 8;90(4):e66-a.

PMID:
10864912
17.

Treatment with anti-gremlin 1 antibody ameliorates chronic hypoxia/SU5416-induced pulmonary arterial hypertension in mice.

Ciuclan L, Sheppard K, Dong L, Sutton D, Duggan N, Hussey M, Simmons J, Morrell NW, Jarai G, Edwards M, Dubois G, Thomas M, Van Heeke G, England K.

Am J Pathol. 2013 Nov;183(5):1461-73. doi: 10.1016/j.ajpath.2013.07.017.

18.

Adenoassociated virus-mediated prostacyclin synthase expression prevents pulmonary arterial hypertension in rats.

Ito T, Okada T, Mimuro J, Miyashita H, Uchibori R, Urabe M, Mizukami H, Kume A, Takahashi M, Ikeda U, Sakata Y, Shimada K, Ozawa K.

Hypertension. 2007 Sep;50(3):531-6. Epub 2007 Jul 16.

PMID:
17635855
19.

Pulmonary prostacyclin synthase overexpression in transgenic mice protects against development of hypoxic pulmonary hypertension.

Geraci MW, Gao B, Shepherd DC, Moore MD, Westcott JY, Fagan KA, Alger LA, Tuder RM, Voelkel NF.

J Clin Invest. 1999 Jun;103(11):1509-15.

20.

Induction of prostacyclin by steady laminar shear stress suppresses tumor necrosis factor-alpha biosynthesis via heme oxygenase-1 in human endothelial cells.

Di Francesco L, Totani L, Dovizio M, Piccoli A, Di Francesco A, Salvatore T, Pandolfi A, Evangelista V, Dercho RA, Seta F, Patrignani P.

Circ Res. 2009 Feb 27;104(4):506-13. doi: 10.1161/CIRCRESAHA.108.191114. Epub 2009 Jan 2.

PMID:
19122175

Supplemental Content

Support Center